BDBM791004 US20260035340, Compound Ref

SMILES CC(C)=Cc1cc(/C=C/C(=O)O)cc(C(=O)NCc2ccc(C)cc2)c1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 791004   

TargetAldo-keto reductase family 1 member C3(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 791004BDBM791004(US20260035340, Compound Ref)
Affinity DataIC50: 70nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C1(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 791004BDBM791004(US20260035340, Compound Ref)
Affinity DataIC50: 1.00E+5nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C4(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 791004BDBM791004(US20260035340, Compound Ref)
Affinity DataIC50: 1.45E+5nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent

TargetAldo-keto reductase family 1 member C2(Human)
University of Nebraska

US Patent
LigandChemical structure of BindingDB Monomer ID 791004BDBM791004(US20260035340, Compound Ref)
Affinity DataIC50: 2.00E+5nMAssay Description:TRKA co-expressed with p75: The assays are based upon DiscoveRx's proprietary Enzyme Fragment Complementation (EFC) technology. In the case of the TR...More data for this Ligand-Target Pair
Ligand Info
In Depth
Date in BDB:
6/17/2026
Entry Details ArticleUS Patent